Motivation: Alternative splicing (AS) is a frequent step in metozoan gene expression whereby the exons of genes are spliced in different combinations to generate multiple isoforms of mature mRNA. Alternative splicing functions to enrich an organism's proteomic complexity and regulates gene expression. Despite its importance, the mechanisms underlying AS and its regulation are not well understood, especially in the context of global gene expression patterns. We present here an algorithm referred to as the Generative model for Alternative Splicing Array Platform (GenASAP) that can predict the levels of AS for thousands of exon skipping events using data generated from custom microarrays. GenASAP uses Bayesian learning in an unsupervised probability model to accurately predict AS levels from the microarray data. GenASAP is capable of learning the hybridization profiles of microarray data, while modeling noise processes and missing or aberrant data. GenASAP has been successfully applied to the global discovery and analysis of AS in mammalian tissues. Results: GenASAP was applied to data obtained from a custom microarray designed for the monitoring of 3,126 AS events in mouse cells and tissues. The microarray design included probes specific for exon body and junction sequences formed by the splicing of exons. Our results show that GenASAP provides accurate predictions for over one third of the total events, as verified by independent RT-PCR assays.
INTRODUCTION
In higher eukaryotes, genes are often composed of multiple exons which must be spliced together to generate mature mRNA that can be translated into protein. Transcription of protein coding genes initially results in a primary transcript from which the intervening sequences or introns are removed and the exons are spliced together. The exons of some genes can be spliced in different combinations to result in structurally and functionally distinct mRNA isoforms. This process, known as alternative splicing (AS) is capable of resulting in orders of magnitude more mRNAs and corresponding proteins than there are genes (Black, 2000; Maniatis, 2002; Matlin, 2005) . In a particularly striking example, transcripts from the Drosophila Dscam gene have the potential to be alternatively spliced in 38,016 different combinations, which is twice the number of genes in the Drosophila genome (Schmucker, 2000) . Similarly, specific genes in mammals also have extraordinary potential for the generation of transcript diversity by AS and it is currently estimated that approximately 74% or more of human genes contain one or more alternative exon (Johnson, 2003) . These findings indicate that AS could account for much of the increased complexity associated with higher eukaryotes, whereas the gene count between species does not account for this increased complexity (Black, 2000; Frey, 2005) .
Other than contributing to the expansion of an organism's genetic repertoire, AS is known to play critical roles in the regulation of development, cellular differentiation, maintenance of the differentiated state, and apoptosis. In addition, disruption of splicing is frequently associated with human diseases (Blencowe, 2000; Cartegni, 2002) . Despite its importance, the mechanisms underlying AS and its regulation are poorly understood. In most previous studies, AS was studied on a case by case basis, whereas technology for analyzing AS on a global scale has only recently been introduced.
In recent years, numerous studies have investigated global properties of AS using databases of expressed sequence tags (EST) and complementary DNA (cDNA) sequence data (Gupta, 2004; Xie, 2002; Pan, 2005; Sorek, 2004; Xu, 2002) . While these studies have been revealing, they are often constrained by the numbers of available EST/cDNA sequences, since these frequently do not represent the entire length of a gene or are only available from a limited number of cell or tissue sources. Additionally, many ESTs/cDNAs are derived from cell lines or tumor tissue, and therefore may not represent physiologically relevant splicing patterns (Hui, 2004; Wang, 2003; Xu, 2003) . More recently, microarrays have become the predominant tool for large scale studies of AS (Blanchette, 2005; Fehlbaum, 2005; Pan, 2004; Ule, 2005) . The common approach is to design probes for the exon bodies and junctions that are involved in the AS events being studied. The array expression is then analyzed and compared across samples and differential expression is used to detect existence of, or changes in, mRNA isoform levels.
We present here an algorithm that allows the quantitative estimation of relative mRNA isoform levels in mammalian cells and tissues. The algorithm was developed for the analysis of data from custom DNA microarrays specifically designed for this task (Pan, 2004) . The algorithm, which we have named GenASAP (Generative model for Alternative Splicing Array Platform), is based on a generative probabilistic model and uses machine learning to estimate relative AS levels in an unsupervised fashion. While it was designed for the prediction of single exon skipping AS events, GenASAP is an extendable model and is capable of handling any number of mRNA splice isoforms and probes. The results produced by GenASAP have already been used to reveal important global regulatory features of AS in adult mammalian tissues (Pan, 2004) .
ALTERNATIVE SPLICING MICROARRAY DATASET
We developed a custom DNA microarray for surveying AS levels on a large scale. This microarray contains probes for 3,126 exon skipping events from 2,647 unique mouse genes. The AS events were primarily selected on the basis of having strong EST/cDNA-based support (i.e. multiple independent ESTs/cDNAs sequences revealed skipping or inclusion of each alternative exon) (Pan, 2005) . The microarray contained multiple probes for each AS event, allowing for redundancy in the measurements, and enabling quantitative analysis. Each event is analyzed using six probes, as shown in Figure 1 . Three body probes are used to monitor each of the three exons involved in the AS event -the constitutive (always included) exons, C1 and C2, and the alternative exon, A. Two junction probes are used to monitor the two junctions formed by the inclusion of the alternative exon and one junction probe monitors the junction formed by the exclusion of the alternative exon and splicing of the constitutive exons . In addition to the aforementioned six probes, an additional probe was included to monitor the intron located between the C1 exon and the A exon. While it was anticipated that this probe would provide useful information on global levels of unspliced pre-mRNA, few transcripts appeared to be unspliced in our initial analyses of mouse tissue AS and we have since omitted intron probe data from our analysis and more recent microarray designs.
The custom microarray described above was manufactured according to our designs by Agilent Technology Inc., and was initially hybridized with fluorescent (Cy3/Cy5)-labeled cDNA prepared from poly-A+ RNA extracted from ten mouse tissues: brain, heart, liver, kidney, intestine, salivary gland, skeletal muscle, spleen, lung, and testis. All hybridizations were performed in duplicate with fluor reversal: thus, each mRNA was examined twice on separate arrays, once in the green (Cy3) channel and once in the red (Cy5) channel. The channels were considered separately, and individual channels were spatially detrended (that is, overall correlations between spot intensity and position on the slide were removed) using Spatial Trend Removal (STR) (Shai, 2005) . We applied variance stabilizing normalization (VSN) to globally align the channels (Huber, 2002) .
Using microarray data generated from the sets of six microarray probes specific for each AS event, our goal was to generate robust algorithm for estimating the relative levels of tissue-specific AS levels for each alternative exon. In principle, measurements could be directly averaged and compared using, for instance, a t-statistic to estimate AS levels. However, the complexity of the noise processes, interactions between the unknown AS levels, and the presence of other hidden variables such as probe sensitivity, make analysis of the microarray dataset well suited for the application of a probability model. We describe such a model in this paper and demonstrate its reliability by comparison with measurements of AS levels from the same tissue samples using RT-PCR assays.
GENASAP -A GENERATIVE MODEL FOR ALTERNATIVE SPLICING ARRAY PLATFORM
We would like to infer the relative levels of the two isoforms contributing to the array measurements. To do this, we model the process that generated the array measurements, learn the maximum likelihood (ML) parameter settings, and infer the conditional distribution of the isoform levels given the array data and the estimated
3 body probes 2 inclusion junction probes 1 exclusion junction probe Fig. 1 . Each AS event on the array is analyzed using six probes, as shown by the black lines. Three body probes monitor the three exons involved in the event, two junction probes monitor the inclusion isoform, and one junction probe monitors the exclusion isoform.
parameters. While the model presented below can be used for evaluating any arbitrary number of isoforms and probes, we use the array described in section 2 as an example to simplify the notation and discussion. We assume that there is a linear relationship between the intensity measured by the probe and the abundance of target mRNA containing the probe binding sequences. Therefore, we model the intensity measured at each probe as a linear combination of the abundance of the two isoforms, plus noise. This can be written as xi = λi1s1 + λi2s2 + i, where xi is one of the six real-value intensity measurements pertaining to a six probe AS event set from the microarray, s1 and s2 are the two unknown real-value abundances of the mRNA isoforms, λi1 and λi2 are the estimated affinity between the two mRNA isoforms and probe i, and i is the additive noise component for probe i. Ideally, we would like to learn a hybridization profile (i.e. a set of probe affinities) for each six probe set targeting a single AS event across the samples. However, this is not possible for two reasons. First, in our particular data set there are only ten tissue samples, which is too few to confidently learn a profile for each AS event. Second, and more importantly, although the AS events represented on the array were mined from EST data found to express alternative isoforms, it is likely that not all events exhibit variable splicing levels across the ten tissues. Learning separate hybridization profiles for each AS event would therefore lead to overfitting, and we resign ourselves to learning global hybridization profiles, shared among all AS events.
To accurately infer the relative levels of the mRNA isoforms, it is crucial to have an appropriate noise model. Microarrays have been previously shown to have scale-dependent noise (Rocke, 2001) . Data preprocessing techniques, such as VSN, reduce this effect by transforming the intensity data to a log or sinh −1 domain 1 . However, for the model's linear isoform combination assumption to be valid, we must maintain the microarray measurements in the intensity domain. Additionally, we must also account for outlying measurements, resulting from faulty probes, aberrations on the array surface, cross-hybridization, and other experimentally introduced errors using an outlier model. So, to account for scale-dependent noise and aberrant measurements, we rewrite the model as where the subscript j indexes isoforms, the scale factor r is a real valued scalar accounting for noise levels at the measured intensity, ζi is a pure noise component representing an aberrant measurement, and the binary indicator, oi ∈ {0, 1} identifies a probe measurements as aberrant (oi = 1) or valid (oi = 0).
The model is shown graphically as a Bayesian Network in Figure  2 . (A Bayesian Network is an acyclic directed graph where each vertex represents a variable in the model and the directed edges represent conditional dependence.) This network visually demonstrates that each array observation, xi, is dependent on both of the isoform abundances, s1 and s2, the scale factor, r, and an outlier indicators, o. The network's roots do not depend on other variables, and are independent a priori.
Under the assumption of independent, zero-mean, normally distributed noise, the conditional probability of the data given the isoform levels, scale, and outlier indicators, can be written as
where N (x; µ, σ 2 ) indicates the density of point x under normal distribution with mean µ and variance σ 2 , and the variance of the noise at probe i is given by ψi, and the mean and variance of the outlier model are given by Ei and Vi respectively.
There are model constraints that arise from the biological nature of the problem. First, the isoform abundances, s, may not take negative values. Similarly, the hybridization profiles, Λ, may not assume negative values, since the presence of an isoform should not reduce the measured intensity. The constraint on the isoform abundances is enforced by setting its prior to a truncated Gaussian distribution, as given by To completely specify the joint probability, we require priors over the remaining noise processes, o and r. The prior for the indicator variable o is parameterized as P (oi) = γ
, where γi is a learned parameter reflecting the probability of each type of probe to be an outlier a priori. There is a need for probe-type specific prior, as we expect the junction probes to show more aberrant measurements. For computational efficiency, we select r from a discrete set of possible values, r ∈ {ρ1, ρ2, . . . , ρC } and set the a priori probability P (r = ρ k ) = 1/C.
Inferring Isoform Levels
We next address the task of inferring the relative levels of the mRNA isoforms. The parameters of the model are shared among all AS events on the arrays, and are comprised of the noise variances, Ψ, outlier probabilities, γ, the set of possible values for the scale factor, {ρ1, ρ2, . . . , ρC }, the outlier model's mean and variance, Ei and Vi, and the hybridization profiles, Λ. Additionally, the generative model contains two types of variables that are unique for each AS event studied. There are observed variables, in this case the microarray observations, x, and there are unknown (latent) variables, which include the isoform levels, s, outlier idicators, o, and the scale factor, r.
If the parameters of the model are specified and known, the posterior distribution of the latent variables can be obtained using Bayes' Rule:
While the parameters could be set by hand, according to a predetermined strategy, another option is to estimate the parameter values for which the likelihood of the model, given by by P (x), is maximized. For example, while there is a clear intuition of the form the hybridization matrix, Λ, should take to reflect the hybridization profiles (i.e. the exclusion isoform should bind strongly to the C1, C2, and C1-C2, probes, while hybridizing weakly or none at all to the other probes), we do not know the precise form and levels of cross hybridization between probes. As we show in section 5, the ML estimate of the hybridization profiles achieve better performance than profiles set by hand.
Computing the likelihood of the model, P (x), requires summing over the latent variables, as shown in Equation 4. In the GenASAP model, exact computation of P (x) turns out to be infeasible. P (x) takes the form of a mixture model, where each mixture component correspond to a particular configuration of r and o. Each mixture component is given by
which is of the form of a truncated Gaussian. Integrating over s thus requires evaluating the partition function of a multivariate truncated Gaussian. In the general case, this task cannot be carried out analytically (Cozman, 1995) . However, the partition function is computable under special circumstances, such as when the variables are independent. One approach in situations such as these is to use sampling methods. These methods were attempted, but were found to be time consuming due to the necessity to generate thousands of samples for each AS event whenever inference was carried out. The approach we take is to use variational methods. Variational methods use approximate inference to circumvent calculating the exact posterior. Variational learning proved to be significantly faster, as approximate inference can be carried out analytically. (Dempster, 1977) . The EM algorithm finds the ML estimate of the parameters by starting with an arbitrary parameter setting, set either manually or randomly. EM then iteratively computes the posterior distribution over hidden variables in the E-step, and maximizes the log-likelihood of the model with respect to the parameters, while keeping the posterior fixed, in the M-step. When the posterior cannot be computed, variational EM replaces the exact posterior with a computationally tractable approximation, and maximizes a lower bound of the log-likelihood.
Variational learning in GenASAP
Under the mean field approximation, the approximate distribution is chosen such that all variables are independent (Neal, 1998) . This type of distribution often can be easily modelled and computed but sacrifices knowledge of the structure inherent in the model. In GenASAP, we make a partial mean field approximation that retains much of the structure of the true posterior. The approximate posterior is given by
where the subscript t indexes over the AS events on the array (each represented by six probes targeting two isoforms). Note that the Q distribution depends on the observed data, x indirectly through the variational parameters (see below). Q(rt) and Q(ot|rt) are discrete distributions, and together represent the responsibility of each of the mixture components. Q(sjt|rt, ot) is parameterized as Q(sjt|rt, ot) ∝ N (sjt; µjtor; σjtor)[sjt ≥ 0]. Thus, the a posteriori interdependence within s is disregarded, but the dependence of s on r and o is retained in the approximation. To avoid overfitting, we constrain Q(ot|rt) to those configurations where at most two of the probes are marked as outliers.
Since we cannot compute the likelihood or log-likelihood of the model, we can no longer maximize it. We can, however, make use of Jensen's inequality to maximize a lower bound of the log-likelihood (Neal, 1998) :
The term F(P, Q) is the free energy of the model 2 . Minimizing the free energy is thus equivalent to maximizing a lower bound 2 F (P, Q) is equivalent to the free energy of the system from statistical physics, if we consider the negative log joint probability, − log P (s, r, o, x), as the energy function of the system and the approximation, Q(s, r, o), as a distribution over the state of the system. The free energy is also equivalent to the Kullback-Liebler (KL) divergence, or relative entropy, between the joint distribution and the approximate posterior of the log-likelihood of the model. The variational EM learning in GenASAP proceeds as follows: 1. Initialize model parameters 2. E-step:
Minimize F(P, Q) with respect to the variational parameters of the Q distribution, {µjtor}, {σjtor}, {Q(ot|r)}, and {Q(rt)}, while keeping the model parameters fixed. 3. M-step: Minimize F(P, Q) with respect to the model parameters, Λ, Ψ, and {ρ1, ρ2, . . . , ρC }, while keeping the variational parameters fixed. 4. Repeat steps 2 and 3 until convergence.
The minimizations in step 2 and 3 can be carried out by setting partial derivatives of the free energy to zero. Note that the Q distribution is subject to the constraints enforced by the axioms of probability, i.e. it must be positive and integrate to 1. The variational updates for steps 2 and 3 are available in the supplementary information. After convergence, we are left with an estimation of the optimal parameters for the model, and an approximation of the posterior distribution. The setting of st, rt, and ot that maximizes Q(st, rt, ot) approximates the maximum a posteriori (MAP) estimate of the outlier indicator, scaling factor, and most usefully, the isoform levels, which are used as estimates of the mRNA isoform abundances.
INTERPRETING THE MODEL'S POSTERIOR TO PREDICT ALTERNATIVE SPLICING
The results presented in this paper were obtained using two stages of learning. In the first stage, the hybridization profile, Λ, is learned on a subset of the data that is selected for quality based on expression as determined by a set of negative controls. In the second step, Λ is kept fixed, and we introduce the additional constraint that the noise is isotropic (Ψ = ψI) and learn on the entire data set. The constraint on the noise is introduced to prevent the model from using only a subset of the six probes for making the final set of predictions. The analysis was repeated twenty times to evaluate consistency, and confidence intervals on the results were computed. Each trial used different a random set of initial parameters and was allowed to run to convergence, where convergence was determined by a change of < 1 × 10 −4 % of the free energy between iterations. The learned set of hybridization profiles, including confidence intervals, are shown in Figure 3a . The profiles fit well with our intuition of what would be expected based on detection of the two splice isoforms. The two sets of hybridization profiles clearly identify the two isoforms by accounting for hybridization to the exon body and junction probes. Moreover, the learned profiles account for unanticipated trends in the data, exhibiting increased cross hybridization in the junction probes, and no hybridization of the excluded isoform to the alternative exon. For instance, while the exclusion junction probe C1-C2 was designed to monitor the exclusion isoform, the entirety of its sequence is present in the inclusion isoform, albeit separated by the alternative exon. So, while we would not expect the inclusion isoform to bind to the exclusion junction well, it is interesting to note that some cross hybridization is detected by the model.
We do not expect all the inferred abundances to be equally accurate. Specifically, since most tissues only express a small subset of the genes, many of the events on the array would have little or no transcription. Additionally, many events would have poor agreement with the model due to the use of global hybridization profiles. A scoring criterion was used that ranks each AS event based on its transcription level and fit to the model. The prediction score, S, is given by St =
. The scores of all the AS events across the ten tissues are sorted and ranked, and each predicted AS level value receives a Tissue Specific Rank (TSR) -a number ranging from 1 to the total number of surveyed AS events (31, 260) .
Since it is the relative amount of the isoforms that is of most interest, we use the inferred distribution of the isoform abundances to obtain an estimate for the relative levels of AS isoforms. We refer to the isoforms that contains and skip the alternative exon as the inclusion and exclusion isoform respectively. Intuitively, the percent of the excluded alternatively spliced isoform, %ASex, is given by %ASex = sex sex+s inc , where sex and s inc are the MAP estimation for the exclusion and inclusion isoform respectively. In preliminary validation of the analysis by reverse transcriptase -polymerase chain reaction (RT-PCR) (Lodish, 2002) it was determined that this naive approach, while correctly predicting the trends in the data, produced slightly biased predictions. This bias seems to have arisen from two sources. First, the model does not allow for a constant offset in the microarray measurement. Second, there is an inherent degeneracy in the model. One could, for example, multiply all the inferred s1 levels, while dividing the corresponding hybridization profile by the same constant to achieve the same reconstruction. We correct this bias by applying a simple transformation to the predictions. We estimate the transformation by fitting the predictions based on the top 50 RT-PCR measurements as determined by the TSR assigned by GenASAP. The final set of predictions is given by %ASex G = a1 sex sex+a 2 s inc + a3. The two affine transform parameters, a1 and a3 correct for a constant offset and multiplier across all predictions, while the parameter a2 corrects for the degeneracy in the model. The parameters were fit by minimizing the root mean squared error (RMSE) between %ASex G and the RT-PCR measurements, %ASex R .
Reproducibility of GenASAP predictions
Recall that each of the twenty trials was initialized randomly with a different set of parameters, potentially leading to different local minimum of the free energy. Yet, the hybridization profiles learned over the twenty trials exhibit remarkable reproducibility. As shown in Figure 3a , the included isoform displays a slight variation across the twenty trials, with a variance of about 2% of the mean of the learned profile. The learned profile for the excluded isoform is even more consistent, with variance 1% of the mean. As we show next, this culminates in nearly identical predictions for the relative isoform levels across the twenty trials.
Comparing the predictions across the twenty trials reveals a high level of consistency, as one would expect given the consistency of the hybridization profiles. The correlation of the predictions across the trials was found to be 0.9989±0.0009. All the raw predictions (before fitting to RT-PCR) from each trial were compared to the equivalent predictions from all other trials. This yielded 5,939,400 comparisons as follows: 3,126 events across 10 tissues gives 31,260 predictions. 20 trials yields 190 pair-wise comparisons for each The %ASex predictions from each trial were compared to all other trials to evaluate consistency. The cumulative distribution of the absolute difference in %ASex across the trials is shown. (c) Similarly, the ranks assigned to the predictions from each trial were compared to all other trials. The cumulative distribution of the absolute difference in tissue specific rank across the trials is shown.
prediction. Of the comparisons, 84% are within 1 %ASex, and more than 99% are within 2 %ASex, demonstrating remarkable consistency of predictions across random restarts of the algorithm. The last evaluation for consistency is for the TSRs (see Section 4). As with the hybridization profiles and predictions, the assigned ranks are consistent across the random restarts. All the TSRs from each trial were compared to the equivalent predictions from all other trials, again yielding 5,939,400 comparisons. 80% of the comparisons shift by less than 0.3% of the range of TSR values, and 99% of the comparisons shift by less than 1.2%.
RT-PCR validation
To evaluate the results obtained from GenASAP, we carried out 241 RT-PCR experiments covering a wide range of %ASex and TSRs. The RT-PCR experiments, while more accurate and reproducible than microarray experiments, are nonetheless semi-quantitative. Figure 4 shows a sample RT-PCR assay carried out for an AS event across the ten mouse tissues. Primer pairs were designed to have matching Tm (59
• C) and were targeted to constant exon sequences flanking each alternative exon. Gel images were recorded using a Syngene gel documentation system and quantified with Gene Snap software. Each column (usually) produced two measurements corresponding to the two isoforms, and the RT-PCR measured relative AS levels were calculated as %ASex R = We used three criteria to evaluate the performance of GenASAP. Each criterion is designed to assess the level of information available for different types of data analysis. The first criterion is correlation between the RT-PCR measurements and the GenASAP's predictions, as measured using the Pearson correlation coefficient. This criterion assesses GenASAP's ability to correctly predict trends and patterns in the AS data. Figure 5b shows that the correlation between the %ASex R and %ASex G is higher than 0.85 for the top 5,000 predictions and higher than 0.75 for the top 10,000 predictions as determined by TSR (solid gray line). Furthermore, the correlation coefficient measure is invariant to the a1 and a3 learned parameters (see Section 4.2). While the parameter a2 may potentially affect the correlation, it corrects for a constant and arbitrary scaling of the isoform levels, and was found to have little affect on the correlation coefficient.
The second criterion used is the RMSE between %ASex R and %ASex G . Once again, we would like to stress that both RT-PCR and microarray experiments are semi-quantitative methods, from which we have attempted to quantify AS levels. The RMSE plot in Figure 5c shows that there is a high level of agreement between the GenASAP's predictions and the RT-PCR measurements. We were able to establish an RMSE of less than 14% for the top 5,000 predictions and less than 17% for the top 10,000. The RMSE measure is, of course, highly dependent on the transformation applied to the predictions. It is therefore may be advisable to carry out RT-PCR validation for new experiments, and adjust for bias in the predictions. This step is not always necessary, and in particular can be avoided in studies that use quantitative changes in AS levels between samples.
The third and final criterion used is GenASAP's ability to correctly predict high, medium, and low exclusion. The domain of %ASex was divided to three overlapping regions of low exclusion (%ASex < 35%), medium exclusion (25% ≤ %ASex ≤ 75%), and high exclusion (%ASex > 65%). The overlap is necessary so as to avoid situations where a prediction may be close to a boundary, yet on the wrong side and therefore marked as erroneous. These situations would arise with any arbitrarily specified thresholds, but are avoided using overlapping regions. Figure 5d shows that 91% of the predictions fall into the correct category for the top 5,000 predictions, and 86% of the events are correctly categorized for the top 10,000 predictions. Interestingly, when considering the entire set of 31,260 predictions, over 80% of the predictions are correctly categorized. The task of categorizing predictions is inherently simpler than predicting the actual level of AS, and GenASAP also performs well in this respect.
THE VALUE OF LEARNING
We have mentioned in Section 3.1) that learning the hybridization profile improves the performance of GenASAP. We show here a set of predictions obtained using the intuitive hybridization profile shown in Figure 5a . This hybridization profile is representative of how an ideal binding profile may appear. In this profile, the isoforms bind evenly and exclusively to the corresponding body and junction probes with no cross hybridization. The rest of the parameters in the GenASAP model were allowed to assume their maximum likelihood values. The algorithm was executed and the predictions ranked. As in the case of the prediction obtained using the learned profile (learned predictions), the predictions obtained using the intuitive profile (intuitive predictions) were fitted to the RT-PCR measurements based on the top 50 ranked predictions, as explained in Section 4. The predictions based on the intuitively-selected hybridization profiles were evaluated using the same three criteria discussed in Section 4.2, and results are shown in Figure 5b , c, and d. A comparison of the learned predictions (solid gray line) greatly outperform the intuitive prediction (dashed black line) on every criteria and in every rank cutoff. The intuitive predictions are similar to what one would obtain by simply comparing the exclusion junction probe, C 1 -C 2 , with the three inclusion isoforms, C 1 -A, A, and A-C 2 , while allowing for outliers. Even when testing the abilities to categorize the events based on high, medium, and low exclusion, the intuitive predictions do not perform satisfactorily, with only the top 5,000 predictions scoring above the 80% accuracy mark, compared with the learned predictions, which are all above the 80% accuracy mark.
DISCUSSION
We have demonstrated the use of a generative model (GenASAP) for correctly modelling the processes involved in generating microarray data for the analysis of alternative splicing levels in mammalian mRNA samples. Using a custom DNA micoarray specifically designed for the quantification of AS, GenASAP is able to extract thousands of accurate predictions of AS levels. Although our array was designed to target two splice isoforms using six probes, GenASAP is an extendable model, capable of handling additional numbers and types of isoforms and probe sets, and including new noise models. Using unsupervised variational learning, GenASAP estimates the maximum likelihood setting of the parameters and infers the relative isoform levels. The predictions obtained from GenASAP correlate well with RT-PCR assays.
One of the key features that makes GenASAP capable of making accurate predictions is the outlier model. The outlier model detects probes that exhibit aberrant behaviour and disregards these probes when inferring the isoform levels. In our experiments we found that roughly 5% of all probes were marked as outliers. In identifying outliers, the two constant exons body probes prove to be critical. The C 1 and C 2 probes allow the model to estimate the overall transcription levels of the mRNA isoforms monitored using the microarray, and thereby efficiently detect outliers. Note that with those two probes removed, we would be left with only a single probe targeting the exclusion isoform. In selected cases we found events for which the exclusion junction probe was marked as providing an aberrant measurement, yet the overall %ASex was predicted accurately.
Another important feature of GenASAP is to provide quality estimates of its predictions in the form of the tissue specific ranks. The ranks provided by GenASAP allow us to focus on the more accurate predictions. Indeed, GenASAP outperforms common supervised methods, such as nearest neighbor, logistic regression, and support vector machines, that were trained using the available RT-PCR measurements (see supplementary information)
GenASAP represents the first and currently only quantitative analysis tool for alternative splicing microarrays. Previous and concurrent microarray studies have attempted either detection of novel AS events (Johnson, 2003) or identification of increased or decreased AS levels in particular samples, as compared to a control sample (Blanchette, 2005; Ule, 2005) . Fehlbaum and colleagues at ExonHit Therapeutics have succeeded in extracting quantitative estimates of AS levels, but require the use of extensive control experiments for their analysis (Fehlbaum, 2005) . GenASAP, on the other hand, requires no further information than the microarray data available.
The GenASAP algorithm is available through http://www.psi. utoronto.ca/GenASAP
